Games developer tinyBuild seeks to boost £500 million market cap by becoming a media company. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Share News (AVCT)

Share Price Information for Avacta (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 225.00
Bid: 224.00
Ask: 226.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.89%)
Open: 214.00
High: 234.50
Low: 214.00
Yest. Close: 221.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Avacta appoints BBI Solutions as manufacturing partner for Covid-19 antigen test

(Sharecast News) - Biotechnology company Avacta on Thursday appointed BBI Solutions as a manufacturing partner for the development of its rapid SARS-CoV-2 antigen test.

6 Aug 20 10:39

IN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical

IN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical

29 Jul 20 19:01

Avacta expands partnership with Daewoong to Covid-19 therapy

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.

29 Jul 20 13:46

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

22 Jul 20 17:57

Avacta's Covid test collaboration with Adeptrix accepted into CONDOR

(Sharecast News) - Avacta Group has started work with the UK government's 'CONDOR' programme, it announced on Wednesday, to evaluate and clinically validate the high throughput Covid-19 bead-assisted mass spectrometry laboratory assay, developed with Adeptrix.

22 Jul 20 16:13

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

13 Jul 20 11:23

Avacta signs Covid sewage test deal with Integumen

(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.

13 Jul 20 09:18

IN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test

IN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test

24 Jun 20 13:55

Avacta upbeat on evaluation of Covid-19 test strips

(Sharecast News) - Avacta Group announced on Wednesday that the first 'Affimer'-based rapid test strips to detect SARS-CoV-2 (Covid-19) spike protein had been developed and evaluated by its partners at Cytiva - formerly GE Healthcare Life Sciences - and reportedly showed positive initial performance data.

24 Jun 20 08:36

'No-swab' saliva test for coronavirus piloted in Britain

LONDON, June 22 (Reuters) - A weekly coronavirus testing regime using a "no-swab" saliva test is being trialled in Southampton, southern England, and could result in a simpler and quicker way to detect outbreaks of the virus, the British governme...

22 Jun 20 08:52

Avacta reports promising findings on potential Covid therapy

(Sharecast News) - Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that its 'Affimer' reagents, which bind to the SARS-COV-2 (Covid-19) virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus, and therefore provide a potential therapy for Covid-19 infection.

18 Jun 20 11:55

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

15 Jun 20 15:52

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

9 Jun 20 11:14

Avacta's Covid-19 test reaches prototype stage

(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.

9 Jun 20 09:30

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

4 Jun 20 14:31

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.